Performance of CellDetect for detection of bladder cancer: Comparison with urine cytology and UroVysion.

[1]  Y. Lotan,et al.  Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis , 2021, Cancers.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  N. Vasdev,et al.  Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. , 2020, Urologic oncology.

[4]  Shahrokh F. Shariat,et al.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. , 2019, European urology.

[5]  M. Miyake,et al.  Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma , 2018, Research and reports in urology.

[6]  M. Babjuk,et al.  An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer , 2018, World Journal of Urology.

[7]  Byron C. Jaeger,et al.  Impact of bladder cancer on health‐related quality of life , 2018, BJU international.

[8]  Yael A. Glickman,et al.  A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study. , 2016, European urology focus.

[9]  N. Heerema,et al.  A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection , 2017, BMC Cancer.

[10]  Qing Chen,et al.  A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer , 2017, PloS one.

[11]  D. Weisenberger,et al.  Genetic and Epigenetic Alterations in Bladder Cancer , 2016, International neurourology journal.

[12]  John D Seigne,et al.  Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. , 2016, The Journal of urology.

[13]  F. Brimo,et al.  Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. , 2015, Urologic oncology.

[14]  O. Yossepowitch,et al.  A novel urine cytology stain for the detection and monitoring of bladder cancer. , 2014, The Journal of urology.

[15]  P. Nietert,et al.  Evaluation of urovysion and cytology for bladder cancer detection , 2013, Cancer cytopathology.

[16]  Herbert Stepp,et al.  Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. , 2013, European urology.

[17]  S. Nazir,et al.  Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic , 2012, BJU international.

[18]  A. Fishman,et al.  Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia , 2010, Diagnostic pathology.

[19]  R. Margalit,et al.  A color discriminating broad range cell staining technology for early detection of cell transformation , 2009, Journal of carcinogenesis.

[20]  L. Martínez-Piñeiro,et al.  Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. , 2009, The Journal of urology.

[21]  Yair Lotan,et al.  Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. , 2009, European urology.

[22]  T. Hajdinjak.  UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. , 2008, Urologic oncology.

[23]  M. Babjuk,et al.  Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma. , 2008, Urology.

[24]  Yair Lotan,et al.  Critical evaluation of urinary markers for bladder cancer detection and monitoring. , 2008, Reviews in urology.

[25]  A. Sagalowsky,et al.  Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder , 2006, BJU international.

[26]  T. Deix,et al.  The role of urinary cytology for detection of bladder cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  J. Epstein,et al.  Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder. , 2001, Human pathology.

[28]  B. Hankey,et al.  Surveillance, Epidemiology, and End Results Program , 1999 .